Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy.

Zhu D., Judge PK., Francis ST., Che Z., Rayner JJ., Buchanan C., Mayne KJ., Stevens W., Bley T., Bhandary N., Byrne C., Cejka V., Chapman D., Cox EF., Dasgupta T., Malijan GB., Nicholas R., Phelan P., Smith E., Tunnicliffe EM., Wooding N., Nangaku M., Cherney DZI., Selby NM., Taal M., Steubl D., Aoqui C., Wanner C., Emberson JR., Landray MJ., Baigent C., Staplin N., Herrington WG., Haynes R., EMPA-KIDNEY Collaborative Group .

DOI

10.1053/j.ajkd.2025.09.022

Type

Journal article

Publication Date

2025-12-11T00:00:00+00:00

Permalink More information Close